Indian Journal Watch: 5 November 2026

Indian Journal Watch, InfectionIndia.com

Indian Journal Watch

5 November 2026

Peer-reviewed microbiology, infectious disease, AMR and infection-control papers from India and South Asia, published or added to PubMed from 3 to 4 November 2026.

Lead articles

Vaccine-preventable disease · Seroepidemiology · Human Vaccines & Immunotherapeutics

Population level immunity to measles and rubella 5 years before and after the MR campaign in urban Vellore, South India

Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2750748 · PubMed 42980466

What
A study from the Wellcome Trust Research Laboratory, Christian Medical College, Vellore, comparing population-level immunity to measles and rubella in urban Vellore five years before and five years after the nationwide measles-rubella (MR) vaccination campaign, as India works towards MR elimination by 2026.
Design
Biobanked samples from two community-based serosurveys (2013 and 2022) were tested for measles- and rubella-specific IgG by ELISA in age- and sex-stratified participants. Generalised additive models assessed age-specific seropositivity, and effective reproduction numbers (Re) were estimated by mixture modelling.
Key findings
A total of 1,029 samples from 2013 and 718 from 2022 were analysed. Measles seroprevalence rose from 33%, 41%, 47% and 48% in the 1-5, 6-15, 16-40 and >40 years age groups in 2013 to 77%, 71%, 89% and 96% in 2022. Rubella seroprevalence rose from 32%, 67%, 76% and 73% to 93%, 84%, 93% and 98%. No significant sex-based differences were observed. Estimated Re declined from 7.4 to 3.6 for measles and from 1.8 to 0.8 for rubella.
Limitations
Data come from a single urban site and two cross-sectional time points; the abstract does not report individual vaccination histories.
Relevance to India
Despite more than 90% vaccination coverage reported in NFHS-5 and NFHS-6, lower measles seroprevalence among children aged 1-15 years indicates persistent immunity gaps; the authors call for continued surveillance and targeted strategies.

Zoonoses · Seroepidemiology · PLoS Neglected Tropical Diseases

Seroepidemiology of human leptospirosis in subtropical Bhutan, 2024

PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0014821 · PubMed 42981271

What
A cross-sectional serosurvey estimating human exposure to Leptospira in subtropical southern Bhutan, where limited diagnostic capacity constrains surveillance, by researchers from the Central Regional Referral Hospital, Gelephu, and the International University of Health and Welfare, Japan.
Design
Adults in six subtropical communities were enrolled by probability-proportional-to-size sampling in September-October 2024. Sera were tested by IgM and IgG ELISA and by the microscopic agglutination test (MAT), which defined seropositivity for serovar identification and multivariable risk-factor analysis.
Key findings
Of 503 adults enrolled, 492 were analysed. MAT-based seroprevalence was 19.3% (95% CI: 16.0 – 23.1), compared with 22.4% by ELISA IgM and 16.1% by ELISA IgG. Among MAT-positive samples (n = 95), the predominant serovars were Australis (49%) and Lai-like (13%). Paddy farming (adjusted OR: 4.74) and drinking unboiled water (adjusted OR: 2.34) were independently associated with seropositivity, as were residence in crowded urban (adjusted OR: 4.08) or urban areas (adjusted OR: 2.94) and lower education.
Limitations
The cross-sectional design cannot establish temporality, and self-reported exposures may be subject to recall bias.
Relevance to India
Approximately one in five adults had serological evidence of prior exposure, more than previously recognised; the data provide a baseline for leptospirosis surveillance in a subtropical area bordering India.

More from the journals

Tuberculosis & mycobacteria

AMR, IPC & healthcare-associated infection

Vector-borne & parasitic diseases

Virology

Outbreaks & public health

Items are summaries of published abstracts and are not clinical advice. Readers should consult the original article. Figures are quoted as reported in each abstract.

Leave a Reply

Your email address will not be published. Required fields are marked *